Opinion/decision on a Paediatric investigation plan (PIP): Pifeltro,doravirine, decision type: , therapeutic area: , PIP number: P/0505/2022

Opinion/decision on a Paediatric investigation plan (PIP): Braftovi,Encorafenib, decision type: , therapeutic area: , PIP number: P/0487/2022

Opinion/decision on a Paediatric investigation plan (PIP): Dupixent,dupilumab, decision type: , therapeutic area: , PIP number: P/0541/2022

Opinion/decision on a Paediatric investigation plan (PIP): binimetinib, decision type: , therapeutic area: , PIP number: P/0488/2022

Opinion/decision on a Paediatric investigation plan (PIP): Tecovirimat (monohydrate), decision type: , therapeutic area: , PIP number: P/0540/2022

Ethical use of animals in medicine testing

Opinion/decision on a Paediatric investigation plan (PIP): Recombinant human A disintegrin and metalloprotease with thrombospind type-1 motifs 13, decision type: , therapeutic area: , PIP number: P/0489/2022

Opinion/decision on a Paediatric investigation plan (PIP): Kisplyx,Lenvatinib, decision type: , therapeutic area: , PIP number: P/0528/2022

Opinion/decision on a Paediatric investigation plan (PIP): Kyntheum,brodalumab, decision type: , therapeutic area: , PIP number: P/0490/2022

Opinion/decision on a Paediatric investigation plan (PIP): Posoleucel, decision type: , therapeutic area: , PIP number: P/0533/2022